What are the plasma half-lives of daunorubicin and cytarabine when administered as Vyxeos liposomal?

When administered as Vyxeos liposomal, the plasma half-lives of total (encapsulated plus unencapsulated) daunorubicin and cytarabine are 31.5 hours (CV 28.5%) and 40.4 hours (CV 24.2%), respectively, with over 99% of both drugs remaining encapsulated within liposomes in plasma.